Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia

Summary

The main of the proposed study is to assess whether the use of the Cox-2 inhibitor Etoricoxib is beneficial for the use in fibromyalgia. We intend to seek whether this medication may improve psychiatric and rheumatologic parameters of the disease.

Timeline

Start

2008-09

Primary completion

2010-10

Completion

2012-12

Drugs

Indications